Last reviewed · How we verify
NCT03742284: SWIS-01
Safety and Performance of SoftOx Wound Irrigation Solution (SWIS) in Acute Wounds
NA trial testing SoftOx Wound Irrigation Solution in Acute Wounds in 12 participants. Status unknown.
31 May 2019
Quick facts
| Lead sponsor | SoftOx Solutions AS |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 12 |
| Start date | 12 November 2018 |
| Primary completion | 31 May 2019 |
| Estimated completion | 15 June 2019 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- SoftOx Wound Irrigation Solution
Conditions studied
- Acute Wounds — all drugs for Acute Wounds →
Sponsor
SoftOx Solutions AS — full company profile →
Who can join
18 and older, any sex, with Acute Wounds. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This pilot study evaluates safety and performance of the Medical device, SoftOx Wound Irrigation Solution (SWIS), in a model for acute wounds.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03742284
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other SoftOx Solutions AS trials
Trials by the same sponsor.
- NCT05710094 — Safety and Tolerability of Single and Multiple Doses of SoftOx Biofilm Eradicator (SBE) in Chronic Leg Wounds · Phase 1 · completed
- NCT05188638 — Safety of Ascending Single and Multiple Doses of Nebulised SoftOx Inhalation Solution in Healthy Subjects · Phase 1 · completed
- NCT04771819 — Safety and Performance of SWIS in Superficial Wounds · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03742284 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by SoftOx Solutions AS
- Last refreshed: 5 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03742284.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing